Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Renal Cell 32Leukemia 26Melanoma 25Kidney Neoplasms 25Leukemia, Myeloid, Chronic-Phase 22Multiple Myeloma 17Lymphoma 17Leukemia, Myelogenous, Chronic, BCR-ABL Positive 16Neoplasms, Plasma Cell 13Lymphoma, Follicular 12Pancreatic Neoplasms 9Lymphoma, Mantle-Cell 8Leukemia, Lymphocytic, Chronic, B-Cell 8Waldenstrom Macroglobulinemia 7Neoplasms 7Lymphoma, Non-Hodgkin 7Lymphoma, Large-Cell, Immunoblastic 7Lymphoma, Large B-Cell, Diffuse 7Lymphoma, B-Cell, Marginal Zone 7Leukemia, Myeloid, Acute 7Burkitt Lymphoma 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia, Myeloid, Accelerated Phase 6Carcinoma, Hepatocellular 6Colorectal Neoplasms 5Urinary Bladder Neoplasms 4Recurrence 4Rectal Neoplasms 4Lung Neoplasms 4Immunoglobulin Light-chain Amyloidosis 4

Interventions

Irinotecan 31Paclitaxel 27Gemcitabine 27Cisplatin 25Docetaxel 20Oxaliplatin 16Fluorouracil 15alvocidib 13Leucovorin 13Carboplatin 13Capecitabine 12Bortezomib 10Early Intervention, Educational 9Topotecan 8Taxes 8Bevacizumab 73-aminopyridine-2-carboxaldehyde thiosemicarbazone 7ixabepilone 6Vorinostat 6Temozolomide 6Sorafenib 6Immunohistochemistry 6Immunoenzyme Techniques 67-hydroxystaurosporine 6tanespimycin 5Pharmacogenomic Testing 5Pemetrexed 5Magnetic Resonance Spectroscopy 5Filgrastim 5Etoposide 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unspecified Adult Solid Tumor, Protocol Specific × Interferon-alpha × Clear all
NCT00004063 2009-04-30

Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer

National Cancer Institute (NCI)

Phase 1/2 Unknown
30 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡